Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (41-50 of 635) with videos related to

Pageof 64
Sort By:
Cardiology and Therapy|August 22, 2019
Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care DatabaseLori D Bash, Kellee White, Mehul D Patel, et al.
American Heart Journal|March 27, 2007
Publication or presentation of results from multicenter clinical trials: evidence from an academic medical centerAslan T Turer, Kenneth W Mahaffey, Kate L Compton, et al.
Coronary Artery Disease|November 25, 2011
Pattern of liver enzyme elevations in acute ST-elevation myocardial infarctionDavid M Lofthus, Susanna R Stevens, Paul W Armstrong, et al.
Diabetes, Obesity & Metabolism|August 8, 2022
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS ProgramJulio C Nunes, Jie Yu, Clare Arnott, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
Rivaroxaban, an oral direct factor Xa inhibitorJonathan P Piccini, Manesh R Patel, Kenneth W Mahaffey, et al.
Advances in Medical Education and Practice|August 18, 2017
A 15-year review of the Stanford Internal Medicine Residency Program: predictors of resident satisfaction and dissatisfactionJames S Kahn, Ronald M Witteles, Kenneth W Mahaffey, et al.
Cardiovascular Digital Health Journal|March 10, 2022
Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitationChristoph B Olivier, Stephanie K Middleton, Natasha Purington, et al.
International Journal of Cardiology|October 16, 2023
Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trialSneha S Jain, Jie Yu, Clare Arnott, et al.
Journal of Diabetes and Its Complications|September 11, 2007
Baseline glucose and left ventricular remodeling after acute myocardial infarctionJosé C Nicolau, Lilia N Maia, João V Vitola, et al.
Diabetes Research and Clinical Practice|April 1, 2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic reviewKarin Rådholm, Jason Hy Wu, Muh Geot Wong, et al.
Pageof 64

Showing results (41-50 of 635) with videos related to

Sort By:
Pageof 64
Cardiology and Therapy|August 22, 2019
Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care DatabaseLori D Bash, Kellee White, Mehul D Patel, et al.
American Heart Journal|March 27, 2007
Publication or presentation of results from multicenter clinical trials: evidence from an academic medical centerAslan T Turer, Kenneth W Mahaffey, Kate L Compton, et al.
Coronary Artery Disease|November 25, 2011
Pattern of liver enzyme elevations in acute ST-elevation myocardial infarctionDavid M Lofthus, Susanna R Stevens, Paul W Armstrong, et al.
Diabetes, Obesity & Metabolism|August 8, 2022
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS ProgramJulio C Nunes, Jie Yu, Clare Arnott, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
Rivaroxaban, an oral direct factor Xa inhibitorJonathan P Piccini, Manesh R Patel, Kenneth W Mahaffey, et al.
Advances in Medical Education and Practice|August 18, 2017
A 15-year review of the Stanford Internal Medicine Residency Program: predictors of resident satisfaction and dissatisfactionJames S Kahn, Ronald M Witteles, Kenneth W Mahaffey, et al.
Cardiovascular Digital Health Journal|March 10, 2022
Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitationChristoph B Olivier, Stephanie K Middleton, Natasha Purington, et al.
International Journal of Cardiology|October 16, 2023
Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trialSneha S Jain, Jie Yu, Clare Arnott, et al.
Journal of Diabetes and Its Complications|September 11, 2007
Baseline glucose and left ventricular remodeling after acute myocardial infarctionJosé C Nicolau, Lilia N Maia, João V Vitola, et al.
Diabetes Research and Clinical Practice|April 1, 2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic reviewKarin Rådholm, Jason Hy Wu, Muh Geot Wong, et al.
Pageof 64